Ariad Pharmaceuticals Inc fka ARIA

[Whosetosay]

br, thanks for that post. Denner has poor risk management, especially around pricing politics, in place and it is taking its toll on investors, which is a shame, because it appears '113 doesn't have the baggage Pona had, that created the wild swings in pps back then. All of that is clearly destabilizing.

Folks here a while should remember our share price peaked before Pona approval, then came down a point or two just before approval. The black box on approval drove the price down 4 or 5 points minutes after the approval announcement. While such a damaging box is not expected with '113, there is a chance we'll peak before the announcement of approval. With Ariad, the rule is 'sell the news'.